Jazz Pharmaceuticals Plc - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Jazz Pharmaceuticals, Inc. on October 5, 2009, covering events that occurred on September 30, 2009. The company is incorporated in Delaware and maintains its principal executive offices in Palo Alto, California.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and administrative events rather than financial performance.
Material Changes
- Board Resignation: Alex Albert resigned as a member of the Board of Directors, effective immediately on September 30, 2009.
- Board Size Reduction: The Board approved a decrease in the total number of authorized directors from twelve (12) to eleven (11).
Outlook, Risks, and Other Events
- Annual Meeting: The 2009 Annual Meeting of Stockholders is scheduled for December 15, 2009, at 10:00 a.m. local time at the company's Palo Alto facility.
- Record Date: Stockholders of record as of the close of business on October 20, 2009, are entitled to notice and to vote at the meeting.
Key Facts for Investor Verification
- Confirm the immediate effective date of Alex Albert's resignation from the Board.
- Verify the updated authorized number of directors is now eleven.
- Note the record date of October 20, 2009, for voting eligibility at the December 15, 2009, Annual Meeting.